Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Total Debt (2016 - 2017)

Historic Total Debt for Lisata Therapeutics (LSTA) over the last 8 years, with Q2 2017 value amounting to $473605.0.

  • Lisata Therapeutics' Total Debt fell 9463.08% to $473605.0 in Q2 2017 from the same period last year, while for Jun 2017 it was $473605.0, marking a year-over-year decrease of 9463.08%. This contributed to the annual value of $5.7 million for FY2016, which is 6232.43% down from last year.
  • According to the latest figures from Q2 2017, Lisata Therapeutics' Total Debt is $473605.0, which was down 9463.08% from $7.6 million recorded in Q1 2017.
  • Lisata Therapeutics' Total Debt's 5-year high stood at $15.0 million during Q3 2014, with a 5-year trough of $473605.0 in Q2 2017.
  • Over the past 5 years, Lisata Therapeutics' median Total Debt value was $7.1 million (recorded in 2016), while the average stood at $8.1 million.
  • Its Total Debt has fluctuated over the past 5 years, first surged by 191538.14% in 2014, then tumbled by 9463.08% in 2017.
  • Quarter analysis of 5 years shows Lisata Therapeutics' Total Debt stood at $744276.0 in 2013, then skyrocketed by 1915.38% to $15.0 million in 2014, then changed by 0.0% to $15.0 million in 2015, then plummeted by 62.32% to $5.7 million in 2016, then tumbled by 91.62% to $473605.0 in 2017.
  • Its Total Debt was $473605.0 in Q2 2017, compared to $7.6 million in Q1 2017 and $5.7 million in Q4 2016.